level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 50 /hr
Hire Dr. Jyotirekha D.
India
USD 50 /hr

A neuroscience doctorate with a passion for science communication and illustration

Profile Summary
Subject Matter Expertise
Services
Writing Technical Writing
Research Meta-Research, Gap Analysis
Product Development Concept Development
Work Experience

Graphic Illustrator

Biopatrika

August 2021 - Present

Education

PhD | Neuroscience

National Institute of Technology Calicut

July 2015 - April 2021

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Sandhya Kumari and Sujith Raj Salian and Arpitha Rao and Shilpa M. Somagond and Ravindra R. Kamble and Aravind Nesaragi and Jyotirekha Das and G. K. Rajanikant and Srinivas Mutalik and Shamprasad Varija Raghu and Satish Kumar Adiga and Guruprasad Kalthur(2021). Quinoline Derivative Enhances Human Sperm Motility and Improves the Functional Competence . Reproductive Sciences. 28. (5). p. 1316--1332. Springer Science and Business Media {LLC}
Rakesh Kumar and R. Thanigaivelan and G. K. Rajanikant and T. Jagadeesha and Jyotirekha Das(2021). Evaluation of hydroxyapatite- and zinc-coated Ti-6Al-4V surface for biomedical application using electrochemical process . Journal of the Australian Ceramic Society. 57. (1). p. 107--116. Springer Science and Business Media {LLC}
Jyotirekha Das and Rajanikant G.K.(2018). Post stroke depression: The sequelae of cerebral stroke . Neuroscience & Biobehavioral Reviews. 90. p. 104--114. Elsevier {BV}
Jyotirekha Das and Rajanikant G. Krishnamurthy(2016). Commentary: Death Associated Protein Kinase 1: A Perp in Cerebral Ischemia . CNS & Neurological Disorders - Drug Targets. 15. (8). p. 874--877. Bentham Science Publishers Ltd.